GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amplitude Surgical (XPAR:AMPLI) » Definitions » Capex-to-Revenue

Amplitude Surgical (XPAR:AMPLI) Capex-to-Revenue : 0.24 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Amplitude Surgical Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Amplitude Surgical's Capital Expenditure for the six months ended in Dec. 2023 was €-11.51 Mil. Its Revenue for the six months ended in Dec. 2023 was €49.06 Mil.

Hence, Amplitude Surgical's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.24.


Amplitude Surgical Capex-to-Revenue Historical Data

The historical data trend for Amplitude Surgical's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplitude Surgical Capex-to-Revenue Chart

Amplitude Surgical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.11 0.11 0.14 0.19

Amplitude Surgical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.15 0.23 0.16 0.24

Competitive Comparison of Amplitude Surgical's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Amplitude Surgical's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amplitude Surgical's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amplitude Surgical's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Amplitude Surgical's Capex-to-Revenue falls into.



Amplitude Surgical Capex-to-Revenue Calculation

Amplitude Surgical's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-19.394) / 100.2
=0.19

Amplitude Surgical's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-11.505) / 49.056
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amplitude Surgical  (XPAR:AMPLI) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Amplitude Surgical Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amplitude Surgical's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Amplitude Surgical (XPAR:AMPLI) Business Description

Traded in Other Exchanges
Address
11 cours Jacques Offenbach, Valence, FRA, 26000
Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (XPAR:AMPLI) Headlines

No Headlines